References
- Annual Report. (2017). Malaysian AIDS Council (MAC). https://www.mac.org.my/pdf/annual-report/Annual-Report_2017.pdf.
- Chawarski, M. C., Vicknasingam, B., Mazlan, M., & Schottenfeld, R. S. (2012). Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia. Drug and Alcohol Dependence, 124(1–2), 177–180. https://doi.org/10.1016/j.drugalcdep.2011.12.024
- Coe, M. A., Pillitteri, J. L., Sembower, M. A., Gerlach, K. K., & Henningfield, J. E. (2019). Kratom as a substitute for opioids: Results from an online survey. Drug and Alcohol Dependence, 202, 24–32. https://doi.org/10.1016/j.drugalcdep.2019.05.005
- Garcia-Romeu, A., Cox, D. J., Smith, K. E., Dunn, K. E., & Griffiths, R. R. (2020). Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug and Alcohol Dependence, 208, 107849. https://doi.org/10.1016/j.drugalcdep.2020.107849
- Grewal, K. S. (1932). Observations on the pharmacology of mitragynine (kratom). Journal of Pharmacology and Experimental Therapeutics, 46(3), 251–271.
- Grundmann, O. (2017). Patterns of Kratom use and health impact in the US-Results from an online survey. Drug Alcohol Depend, 176, 63–70. https://doi.org/10.1016/j.drugalcdep.2017.03.007
- Hemby, S. E., McIntosh, S., Leon, F., Cutler, S. J., & McCurdy, C. R. (2019). Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine. Addiction Biology, 24(5), 874–885. https://doi.org/10.1111/adb.12639
- Narayanan, S., Vicknasingam, B., & Robson, N. H. M. (2011). The transition to harm reduction: Understanding the role of non-governmental organisations in Malaysia. The International Journal on Drug Policy, 22(4), 311–317. https://doi.org/10.1016/j.drugpo.2011.01.002
- Prozialeck, W. C., Avery, B. A., Boyer, E. W., Grundmann, O., Henningfield, J. E., Kruegel, A. C., McMahon, L. R., McCurdy, C. R., Swogger, M. T., Veltri, C. A., & Singh, D. (2019). Kratom policy: The challenge of balancing therapeutic potential with public safety. The International Journal on Drug Policy, 70, 70–77. https://doi.org/10.1016/j.drugpo.2019.05.003
- Saref, A., Suraya, S., Singh, D., Grundmann, O., Narayanan, S., Swogger, M. T., Prozialeck, W. C., Boyer, E., & Balasingam, V. (2020). Self-report data on regular consumption of illicit drugs and HIV risk behaviors after kratom (Mitragyna Speciosa Korth.) Initiation among illicit drug users in Malaysia. Journal of Psychoactive Drugs, 52(2), 138–144.
- Singh, D., Chear, Y. N. J., Narayanan, S., Leon, F., Sharma, A., McCurdy, C. R., Avery, B. A., & Balasingam, V. (2020). Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users. Journal of Ethnopharmacology, 249, 112462. https://doi.org/10.1016/j.jep.2019.112462
- Singh, D., Narayanan, S., Grundmann, O., Dzulkapli, E., & Vicknasingam, B. (2019). Effects of kratom (Mitragyna Speciosa Korth.) use in regular users. Substance Use & Misuse, 54(14), 2284–2289.
- Singh, D., Narayanan, S., & Vicknasingam, B. (2016). Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Research Bulletin, 126(1), 41–46. https://doi.org/10.1016/j.brainresbull.2016.05.004
- Smith, K. E., & Lawson, T. (2017). Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug and Alcohol Dependence, 180, 340–348. https://doi.org/10.1016/j.drugalcdep.2017.08.034
- Swogger, M. T., & Walsh, Z. (2018). Kratom use and mental health: A systematic review. Drug and Alcohol Dependence, 183, 134–140. https://doi.org/10.1016/j.drugalcdep.2017.10.012
- UNAIDS. (2020). https://www.unaids.org/en/resources/fact-sheet.
- Vicknasingam, B., Narayanan, S., Beng, T., & Mansor, S. M. (2010). The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. The International Journal on Drug Policy, 21(4), 283–288. https://doi.org/10.1016/j.drugpo.2009.12.003
- Yue, K., Kopajtic, T. A., & Katz, J. L. (2018). Abuse liability of mitragynine assessed with a self-administration procedure in rats. Psychopharmacology, 235(10), 2823–2829. https://doi.org/10.1007/s00213-018-4974-9